Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triamcinolone acetonide + bupivacaine hydrochloride + isopropyl alcohol + dexamethasone sodium
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Parenteral, Intramuscular, Intraarticular, Intralesional
01
Overview
This appears to be a **nonstandard compounded combination product description** referring to a mixture containing the corticosteroids triamcinolone acetonide and dexamethasone sodium plus the local anesthetic bupivacaine hydrochloride, with isopropyl alcohol as an antiseptic/excipient rather than a therapeutic active ingredient. Mechanistically, triamcinolone acetonide and dexamethasone act as glucocorticoid receptor agonists that suppress inflammatory gene transcription, while bupivacaine blocks voltage-gated sodium channels to provide local anesthesia. However, the exact four-component combination named here could not be verified as a distinct marketed or clinical-stage drug product from the supplied evidence; the provided indication text instead matches labeling for injectable corticosteroid products and related procedural kits rather than a clearly identified unique drug asset.
- Other names
- triamcinolone acetonide + bupivacaine hydrochloride + isopropyl alcohol + dexamethasone sodium
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on triamcinolone acetonide + bupivacaine hydrochloride + isopropyl alcohol + dexamethasone sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triamcinolone acetonide + bupivacaine hydrochloride + isopropyl alcohol + dexamethasone sodium.